PRL and myeloid sarcoma: In elucidating the immune correlates of PRL, we used freshly isolated samples from a cohort of patients who were clinically and radiologically inactive (no new lesions or clinical relapses) and untreated for at least 6 months (Table 1), providing an opportunity to probe into chronic active MS-related pathology in an unperturbed setting.